BC
RGEN icon

Bridgefront Capital’s Repligen RGEN Stock Holding History

Bridgefront Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$892K Buy
6,541
+3,132
+92% +$385K 0.24% 132
2026
Q1 		$402K Buy
+3,409
New +$476K 0.1% 316
2025
Q1 		– Sell
-3,904
Closed -$562K – 810
2024
Q4 		$562K Buy
+3,904
New +$560K 0.19% 170
2022
Q3 		– Sell
-2,253
Closed -$366K – 440
2022
Q2 		$366K Buy
+2,253
New +$356K 0.41% 84
2022
Q1 		– Sell
-822
Closed -$218K – 399
2021
Q4 		$218K Buy
+822
New +$221K 0.21% 222
2021
Q2 		– Sell
-1,194
Closed -$232K – 854
2021
Q1 		$232K Buy
+1,194
New +$245K 0.07% 521

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bridgefront Capital's RGEN Position: Q2 2026 in Review

Bridgefront Capital increased its Repligen (RGEN) stake by 92% in Q2 2026, buying an estimated $385K and bringing the position to 6,541 shares worth $892K. The position accounts for 0.24% of the portfolio, ranked #132.

Bridgefront Capital first reported a position in RGEN in Q1 2021 and has held it in 6 quarters since. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Bridgefront Capital held 6,541 shares of Repligen worth $892K as of Q2 2026.
  • Bridgefront Capital bought 3,132 Repligen shares in Q2 2026, an estimated $385K.
  • Repligen made up 0.24% of Bridgefront Capital's portfolio in Q2 2026, its #132 holding.
  • Bridgefront Capital first reported a position in Repligen in Q1 2021 and has held it in 6 quarters since.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.